OHR/AVR118

· Ohr Pharmaceutical Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OHR/AVR118, covering 2012-11-27 to 2012-11-27. Get the full timeline:

Most recent: Clinical Trial Update: Open Label Study With OHR/AVR118 in Advanced Cancer Patients With Anorexia-Cachexia [Phase 2]